UltraTech Cement share price ends at ₹12,362; gains 0.71% on November 11
Anupama VM
- 0 min read
Last Updated: 11th November 2026 - 05:34 pm
Key Takeaways
UltraTech Cement finished at ₹12,362, up ₹87 or 0.71%, after trading through a wide ₹243 range between ₹12,217 and ₹12,460.
The close remained more than ₹850 above its 200-day DMA and more than ₹1,000 above the 50-day DMA.
One-month return stood at 15.8%, while three-month, six-month and one-year returns were all positive but below 6%.
UltraTech Cement share price closed November 11 at ₹12,362, gaining ₹87 or 0.71%. The stock opened at ₹12,390 against a previous close of ₹12,275. It traded between ₹12,217 and ₹12,460, creating a wide ₹243 session range. The final price was ₹98 below the high and ₹145 above the low.
Volume stood at 283,154 shares. UltraTech remained substantially above each of its longer moving averages. The 50-day DMA was ₹11,324.30, leaving the close ₹1,037.70 higher. The 100-day DMA stood at ₹11,372.70. The 200-day DMA was ₹11,508.20, which put the November 11 closing price ₹853.80 above that level.
Across 52 weeks, UltraTech had ranged from ₹10,325 to ₹13,110. The closing price was ₹2,037 above the annual low and ₹748 below the annual high. The full annual span measured ₹2,785.
Return periods were positive across the board. One-month performance was the strongest at 15.80%. The three-month return stood at 2.69%, six-month performance at 3.45%, and one-year return at 5.41%. The one-month figure exceeded the one-year reading by 10.39 percentage points. UltraTech's November 11 data therefore combined a positive close with a broad intraday range and a sizeable gap between the market price and all three principal moving averages.
Frequently Asked Questions
What was the UltraTech Cement share price on November 11?
How far above its 200-day DMA was UltraTech?
What was UltraTech Cement's one-month return?
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.